Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In this report, the United States Antifungal Agents market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Antifungal Agents in these regions, from 2018 to 2025 (forecast).
United States Antifungal Agents market competition by top manufacturers/players, with Antifungal Agents sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Asperqillus
Alternaria
Abbott Laboratories
Pfizer
Glaxosmithkline
Bayer Healthcare
Novartis
Sanofi-Aventis
Merck & Co.
Kramer Laboratories
Enzon Pharmaceuticals
Gilead
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Echinocandins
Azoles
Ployenes
Allylamines
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antifungal Agents for each application, including
Aspergillosis
Dermatophytosis
Candidiasis
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Antifungal Agents Market Report 2019
1 Antifungal Agents Overview
1.1 Product Overview and Scope of Antifungal Agents
1.2 Classification of Antifungal Agents by Product Category
1.2.1 United States Antifungal Agents Market Size (Sales Volume) Comparison by Type (2014-2024)
1.2.2 United States Antifungal Agents Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Echinocandins
1.2.4 Azoles
1.2.5 Ployenes
1.2.6 Allylamines
1.2.7 Others
1.3 United States Antifungal Agents Market by Application/End Users
1.3.1 United States Antifungal Agents Market Size (Consumption) and Market Share Comparison by Application (2014-2024)
1.3.2 Aspergillosis
1.3.3 Dermatophytosis
1.3.4 Candidiasis
1.3.5 Others
1.4 United States Antifungal Agents Market by Region
1.4.1 United States Antifungal Agents Market Size (Value) Comparison by Region (2014-2024)
1.4.2 The West Antifungal Agents Status and Prospect (2014-2024)
1.4.3 Southwest Antifungal Agents Status and Prospect (2014-2024)
1.4.4 The Middle Atlantic Antifungal Agents Status and Prospect (2014-2024)
1.4.5 New England Antifungal Agents Status and Prospect (2014-2024)
1.4.6 The South Antifungal Agents Status and Prospect (2014-2024)
1.4.7 The Midwest Antifungal Agents Status and Prospect (2014-2024)
1.5 United States Market Size (Value and Volume) of Antifungal Agents (2014-2024)
1.5.1 United States Antifungal Agents Sales and Growth Rate (2014-2024)
1.5.2 United States Antifungal Agents Revenue and Growth Rate (2014-2024)
2 United States Antifungal Agents Market Competition by Players/Suppliers
2.1 United States Antifungal Agents Sales and Market Share of Key Players/Suppliers (2014-2019)
2.2 United States Antifungal Agents Revenue and Share by Players/Suppliers (2014-2019)
2.3 United States Antifungal Agents Average Price by Players/Suppliers (2014-2019)
2.4 United States Antifungal Agents Market Competitive Situation and Trends
2.4.1 United States Antifungal Agents Market Concentration Rate
2.4.2 United States Antifungal Agents Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antifungal Agents Manufacturing Base Distribution, Sales Area, Product Type
3 United States Antifungal Agents Sales (Volume) and Revenue (Value) by Region (2014-2019)
3.1 United States Antifungal Agents Sales and Market Share by Region (2014-2019)
3.2 United States Antifungal Agents Revenue and Market Share by Region (2014-2019)
3.3 United States Antifungal Agents Price by Region (2014-2019)
4 United States Antifungal Agents Sales (Volume) and Revenue (Value) by Type (Product Category) (2014-2019)
4.1 United States Antifungal Agents Sales and Market Share by Type (Product Category) (2014-2019)
4.2 United States Antifungal Agents Revenue and Market Share by Type (2014-2019)
4.3 United States Antifungal Agents Price by Type (2014-2019)
4.4 United States Antifungal Agents Sales Growth Rate by Type (2014-2019)
5 United States Antifungal Agents Sales (Volume) by Application (2014-2019)
5.1 United States Antifungal Agents Sales and Market Share by Application (2014-2019)
5.2 United States Antifungal Agents Sales Growth Rate by Application (2014-2019)
5.3 Market Drivers and Opportunities
6 United States Antifungal Agents Players/Suppliers Profiles and Sales Data
6.1 Asperqillus
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Antifungal Agents Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Asperqillus Antifungal Agents Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Alternaria
6.2.2 Antifungal Agents Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Alternaria Antifungal Agents Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Abbott Laboratories
6.3.2 Antifungal Agents Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Abbott Laboratories Antifungal Agents Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Antifungal Agents Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Antifungal Agents Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 Glaxosmithkline
6.5.2 Antifungal Agents Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Glaxosmithkline Antifungal Agents Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 Bayer Healthcare
6.6.2 Antifungal Agents Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bayer Healthcare Antifungal Agents Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Novartis
6.7.2 Antifungal Agents Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis Antifungal Agents Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 Sanofi-Aventis
6.8.2 Antifungal Agents Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Sanofi-Aventis Antifungal Agents Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
6.9 Merck & Co.
6.9.2 Antifungal Agents Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck & Co. Antifungal Agents Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Main Business/Business Overview
6.10 Kramer Laboratories
6.10.2 Antifungal Agents Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Kramer Laboratories Antifungal Agents Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Main Business/Business Overview
6.11 Enzon Pharmaceuticals
6.12 Gilead
7 Antifungal Agents Manufacturing Cost Analysis
7.1 Antifungal Agents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antifungal Agents
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Antifungal Agents Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antifungal Agents Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Antifungal Agents Market Size (Value and Volume) Forecast (2019-2024)
11.1 United States Antifungal Agents Sales Volume, Revenue Forecast (2019-2024)
11.2 United States Antifungal Agents Sales Volume Forecast by Type (2019-2024)
11.3 United States Antifungal Agents Sales Volume Forecast by Application (2019-2024)
11.4 United States Antifungal Agents Sales Volume Forecast by Region (2019-2024)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
